Summary: | Nicotinic acid adenine dinucleotide phosphate (NAADP) gates two-pore channels 1 and 2 (TPC1 and TPC2) to elicit endo-lysosomal (EL) Ca<sup>2+</sup> release. NAADP-induced EL Ca<sup>2+</sup> signals may be amplified by the endoplasmic reticulum (ER) through the Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release mechanism (CICR). Herein, we aimed at assessing for the first time the role of EL Ca<sup>2+</sup> signaling in primary cultures of human metastatic colorectal carcinoma (mCRC) by exploiting Ca<sup>2+</sup> imaging and molecular biology techniques. The lysosomotropic agent, Gly-Phe β-naphthylamide (GPN), and nigericin, which dissipates the ΔpH which drives Ca<sup>2+</sup> refilling of acidic organelles, caused massive Ca<sup>2+</sup> release in the presence of a functional inositol-1,4,5-trisphosphate (InsP<sub>3</sub>)-sensitive ER Ca<sup>2+</sup> store. Liposomal delivery of NAADP induced a transient Ca<sup>2+</sup> release that was reduced by GPN and NED-19, a selective TPC antagonist. Pharmacological and genetic manipulations revealed that the Ca<sup>2+</sup> response to NAADP was triggered by TPC1, the most expressed TPC isoform in mCRC cells, and required ER-embedded InsP<sub>3</sub> receptors. Finally, NED-19 and genetic silencing of TPC1 reduced fetal calf serum-induced Ca<sup>2+</sup> signals, proliferation, and extracellular signal-regulated kinase and Akt phoshorylation in mCRC cells. These data demonstrate that NAADP-gated TPC1 could be regarded as a novel target for alternative therapies to treat mCRC.
|